Veru Inc (VERU) Stock Price

2.32 ▲ +0.06 (+2.65%)
Open: 2.30 Vol: 266.9K Day's range: 2.22 - 2.35 Dec 19, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
VERU Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 2.30▲ 2.32▼ 2.32▼ 2.33▼ 2.39▼
MA10 2.30▲ 2.30▲ 2.29▲ 2.45▼ 2.79▼
MA20 2.31▲ 2.28▲ 2.26▲ 2.42▼ 3.02▼
MA50 2.28▲ 2.30▲ 2.39▼ 2.92▼ 1.56▲
MA100 2.28▲ 2.43▼ 2.44▼ 3.03▼ 1.20▲
MA200 2.33▼ 2.43▼ 2.46▼ 1.79▲ 3.45▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.002▼ 0.008▲ 0.015▲ 0.011▲ -0.206▼
RSI 53.941▲ 52.770▲ 48.694▼ 39.543▼ 48.850▼
STOCH 46.528     84.024▲ 77.062     20.978     10.317▼
WILL %R -33.333     -13.043▲ -44.444     -71.698     -91.532▼
CCI -63.730     50.355     46.434     -124.518▼ -78.097    
Latest Filters Detected On VERU
CDL $VERU Harami Candlestick Pattern Detected Set Alert
Veru Inc News
Why Veru Inc. Is Rising In Pre-market?
Tuesday, June 24, 2025 06:05 AM
(RTTNews) - Veru Inc. (VERU) announced positive topline efficacy and safety results from the maintenance extension portion of the Phase 2b QUALITY clinical study. The company said the Phase 2b ...
Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal ...
Wednesday, May 28, 2025 03:30 AM
--Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial ...
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit
Wednesday, April 16, 2025 01:30 AM
About Veru Inc.Veru is a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases. The Company’s drug ...
VERU historical stock data
date open high low close volume
19/12/25 2.30 2.35 2.22 2.32 266,896
18/12/25 2.39 2.41 2.20 2.26 893,486
17/12/25 2.45 2.60 2.17 2.23 410,240
16/12/25 2.40 2.4494 2.335 2.44 141,290
15/12/25 2.46 2.56 2.38 2.39 73,112
12/12/25 2.54 2.63 2.42 2.42 97,158
11/12/25 2.54 2.56 2.47 2.56 77,286
10/12/25 2.63 2.6351 2.51 2.57 45,634
09/12/25 2.67 2.70 2.5511 2.63 119,036
08/12/25 2.46 2.67 2.46 2.65 159,392
Quote Details
52wk Low:0.364
52wk High:4.59
Vol:266.9K
Avg Vol(3m):3.3M
1Y Chng:+211.70%
1M Chng:-9.38%
Add to Watch List
More Information
Index US Composite
Market Cap. 36.27M